Literature DB >> 28102587

Dietary α-cyclodextrin reduces atherosclerosis and modifies gut flora in apolipoprotein E-deficient mice.

Toshihiro Sakurai1,2, Akiko Sakurai1, Ye Chen3, Boris L Vaisman1, Marcelo J Amar1, Milton Pryor1, Seth G Thacker1, Xue Zhang3, Xujing Wang3, Yubo Zhang4, Jun Zhu4, Zhi-Hong Yang1, Lita A Freeman1, Alan T Remaley1,5.   

Abstract

SCOPE: α-Cyclodextrin (α-CD), a cyclic polymer of glucose, has been shown to lower plasma cholesterol in animals and humans; however, its effect on atherosclerosis has not been previously described. METHODS AND
RESULTS: apoE-knockout mice were fed either low-fat diet (LFD; 5.2% fat, w/w), or Western high fat diet (21.2% fat) containing either no additions (WD), 1.5% α-CD (WDA); 1.5% β-CD (WDB); or 1.5% oligofructose-enriched inulin (WDI). Although plasma lipids were similar after 11 weeks on the WD vs. WDA diets, aortic atherosclerotic lesions were 65% less in mice on WDA compared to WD (P < 0.05), and similar to mice fed the LFD. No effect on atherosclerosis was observed for the other WD supplemented diets. By RNA-seq analysis of 16S rRNA, addition of α-CD to the WD resulted in significantly decreased cecal bacterial counts in genera Clostridium and Turicibacterium, and significantly increased Dehalobacteriaceae. At family level, Comamonadaceae significantly increased and Peptostreptococcaceae showed a negative trend. Several of these bacterial count changes correlated negatively with % atherosclerotic lesion and were associated with increased cecum weight and decreased plasma cholesterol levels.
CONCLUSION: Addition of α-CD to the diet of apoE-knockout mice decreases atherosclerosis and is associated with changes in the gut flora.
© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Atherosclerosis; Cyclodextrin; Dietary fiber; Gut flora

Mesh:

Substances:

Year:  2017        PMID: 28102587      PMCID: PMC5548635          DOI: 10.1002/mnfr.201600804

Source DB:  PubMed          Journal:  Mol Nutr Food Res        ISSN: 1613-4125            Impact factor:   5.914


  43 in total

1.  Angiotensin II type 1 receptor blocker telmisartan suppresses superoxide production and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice.

Authors:  Tomofumi Takaya; Seinosuke Kawashima; Masakazu Shinohara; Tomoya Yamashita; Ryuji Toh; Naoto Sasaki; Nobutaka Inoue; Ken-ichi Hirata; Mitsuhiro Yokoyama
Journal:  Atherosclerosis       Date:  2005-09-12       Impact factor: 5.162

2.  Selected indigestible oligosaccharides affect large bowel mass, cecal and fecal short-chain fatty acids, pH and microflora in rats.

Authors:  J M Campbell; G C Fahey; B W Wolf
Journal:  J Nutr       Date:  1997-01       Impact factor: 4.798

3.  Beneficial effects of high dietary fiber intake in patients with type 2 diabetes mellitus.

Authors:  M Chandalia; A Garg; D Lutjohann; K von Bergmann; S M Grundy; L J Brinkley
Journal:  N Engl J Med       Date:  2000-05-11       Impact factor: 91.245

4.  Treatment with KLEPTOSE® CRYSMEB reduces mouse atherogenesis by impacting on lipid profile and Th1 lymphocyte response.

Authors:  Fabrizio Montecucco; Sébastien Lenglet; Federico Carbone; Silvia Boero; Graziano Pelli; Fabienne Burger; Aline Roth; Maria Bertolotto; Alessio Nencioni; Michele Cea; Franco Dallegri; Rodrigo A Fraga-Silva; Laëtitia Fougère; Claire Elfakir; Anne-Laure Gassner; Serge Rudaz; Xavier Parissaux; Daniel Wils; Marc Salomé; Nicolas Vuilleumier; Alessandro Poggi; François Mach
Journal:  Vascul Pharmacol       Date:  2015-04-25       Impact factor: 5.773

5.  Role of dietary propionic acid and bile acid excretion in the hypocholesterolemic effects of oligosaccharides in rats.

Authors:  M A Levrat; M L Favier; C Moundras; C Rémésy; C Demigné; C Morand
Journal:  J Nutr       Date:  1994-04       Impact factor: 4.798

6.  In vitro action of human and porcine alpha-amylases on cyclomalto-oligosaccharides.

Authors:  H Kondo; H Nakatani; K Hiromi
Journal:  Carbohydr Res       Date:  1990-09-05       Impact factor: 2.104

7.  Fermentable carbohydrates exert a more potent cholesterol-lowering effect than cholestyramine.

Authors:  M L Favier; C Moundras; C Demigné; C Rémésy
Journal:  Biochim Biophys Acta       Date:  1995-09-14

8.  Short chain fatty acids in human large intestine, portal, hepatic and venous blood.

Authors:  J H Cummings; E W Pomare; W J Branch; C P Naylor; G T Macfarlane
Journal:  Gut       Date:  1987-10       Impact factor: 23.059

9.  Metagenomic biomarker discovery and explanation.

Authors:  Nicola Segata; Jacques Izard; Levi Waldron; Dirk Gevers; Larisa Miropolsky; Wendy S Garrett; Curtis Huttenhower
Journal:  Genome Biol       Date:  2011-06-24       Impact factor: 13.583

10.  Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms.

Authors:  Hua V Lin; Andrea Frassetto; Edward J Kowalik; Andrea R Nawrocki; Mofei M Lu; Jennifer R Kosinski; James A Hubert; Daphne Szeto; Xiaorui Yao; Gail Forrest; Donald J Marsh
Journal:  PLoS One       Date:  2012-04-10       Impact factor: 3.240

View more
  5 in total

1.  Low amounts of dietary fibre increase in vitro production of short-chain fatty acids without changing human colonic microbiota structure.

Authors:  Daisuke Sasaki; Kengo Sasaki; Naoko Ikuta; Takahiro Yasuda; Itsuko Fukuda; Akihiko Kondo; Ro Osawa
Journal:  Sci Rep       Date:  2018-01-11       Impact factor: 4.379

2.  Systematic evaluation of the gut microbiome of swamp eel (Monopterus albus) by 16S rRNA gene sequencing.

Authors:  Xuan Chen; Shaoming Fang; Lili Wei; Qiwang Zhong
Journal:  PeerJ       Date:  2019-12-20       Impact factor: 2.984

Review 3.  Tackling Atherosclerosis via Selected Nutrition.

Authors:  Anna Vesnina; Alexander Prosekov; Victor Atuchin; Varvara Minina; Anastasia Ponasenko
Journal:  Int J Mol Sci       Date:  2022-07-26       Impact factor: 6.208

Review 4.  Nutraceuticals as therapeutic agents for atherosclerosis.

Authors:  Joe W E Moss; Jessica O Williams; Dipak P Ramji
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-02-14       Impact factor: 5.187

5.  Methyl-β-cyclodextrin suppresses the monocyte-endothelial adhesion triggered by lipopolysaccharide (LPS) or oxidized low-density lipoprotein (oxLDL).

Authors:  Guo Chen; Yun Zhou; Wendiao Zhang; Ying Qin; Bo Wei; Yanan Sun; Yong Chen
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.